Symposium
Endotyping: the means to personalised medicine in lung disease
Translational
Aims : The aims of the session are to present the concept of endotyping in lung disease, describe how combinations of clinical and ‘omic data and detailed bioinformatics analyses of biomarkers can be used to endotype lung diseases.
Target audience :
Allergologist, Clinician, General practitioner, Pulmonologist, Respiratory physician, Fellow, Junior member, Patient, Pharmaceutical industry representative, Scientist
10:45
Defining endotyping airway diseases
G. Anderson (Parkville (VIC), Australia)
CoI
3477
11:15
Application of personalised medicine in lung cancer
J. Wolf (Cologne, Germany)
CoI
3478
11:45
The omics approach to defining endotypes and personalising treatment pathways in asthma
S. Wenzel (Pittsburgh, United States of America)
CoI
3479
12:15
The future of personalised medicine in COPD
A. Agusti Garcia-Navarro (Barcelona, Spain)
CoI
3480
. . .
